MedPath

HTC-867

Generic Name
HTC-867

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Phase 1
Completed
Conditions
Schizophrenia
Interventions
First Posted Date
2010-12-29
Last Posted Date
2010-12-29
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Target Recruit Count
56
Registration Number
NCT01268124

Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

Phase 1
Terminated
Conditions
Healthy Subjects
Interventions
Other: Placebo
First Posted Date
2009-01-22
Last Posted Date
2009-09-02
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Target Recruit Count
72
Registration Number
NCT00827489
© Copyright 2025. All Rights Reserved by MedPath